Karpas Strategies, LLC Bristol Myers Squibb CO Transaction History

Karpas Strategies, LLC

$262 Million
Q2 2024

A detailed history of Karpas Strategies, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Karpas Strategies, LLC holds 33,259 shares of BMY stock, worth $1.91 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares

33,259

Previous 33,242 0.05%

Holding current value

$1.91 Million

Previous $1.8 Million 23.36%

% of portfolio

0.53%

Previous 0.68%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$40.25 - $52.99 $684 - $900	17 Added 0.05%	33,259 $1.38 Million
Q1 2024 May 06, 2024	BUY	$47.98 - $54.4 $767 - $870	16 Added 0.05%	33,242 $1.8 Million
Q4 2023 Feb 07, 2024	BUY	$48.48 - $57.85 $678 - $809	14 Added 0.04%	33,226 $1.7 Million
Q3 2023 Nov 09, 2023	BUY	$57.89 - $64.73 $694 - $776	12 Added 0.04%	33,212 $1.93 Million
Q2 2023 Aug 10, 2023	BUY	$63.71 - $70.74 $637 - $707	10 Added 0.03%	33,200 $2.12 Million
Q1 2023 May 02, 2023	BUY	$65.71 - $74.53 $657 - $745	10 Added 0.03%	33,190 $2.3 Million
Q4 2022 Feb 07, 2023	BUY	$68.48 - $81.09 $547 - $648	8 Added 0.02%	33,180 $2.39 Million
Q3 2022 Oct 28, 2022	SELL	$0.13 - $76.84 $70 - $41,570	-541 Reduced 1.6%	33,172 $2.36 Million
Q2 2022 Jul 19, 2022	BUY	$72.62 - $79.98 $653 - $719	9 Added 0.03%	33,713 $2.6 Million
Q1 2022 Apr 19, 2022	BUY	$61.48 - $73.72 $55,577 - $66,642	904 Added 2.76%	33,704 $2.46 Million
Q4 2020 Jan 27, 2021	BUY	$57.74 - $65.43 $41,572 - $47,109	720 Added 2.24%	32,800 $2.04 Million
Q2 2019 Jul 25, 2019	SELL	$44.62 - $49.34 $2,677 - $2,960	-60 Reduced 0.19%	32,080 $1.46 Million
Q1 2019 Apr 18, 2019	BUY	$45.12 - $53.8 $2,707 - $3,228	60 Added 0.19%	32,140 $1.53 Million
Q3 2017 Nov 08, 2017	BUY	$55.23 - $63.74 $1.77 Million - $2.04 Million	32,080	32,080 $2.05 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $122B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Karpas Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Karpas Strategies, LLC with notifications on news.

Account

Karpas Strategies, LLC Bristol Myers Squibb CO Transaction History